Lifevantage Retained Earnings (Accumulated Deficit) 2010-2024 | LFVN

Lifevantage retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Lifevantage Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $-109
2023 $-98
2022 $-98
2021 $-92
2020 $-93
2019 $-100
2018 $-103
2017 $-107
2016 $-109
2015 $-114
2014 $-111
2013 $-76
2012 $-77
2011 $-88
2010 $-38
2009 $
Lifevantage Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $-109
2024-03-31 $-108
2023-12-31 $-107
2023-09-30 $-104
2023-06-30 $-98
2023-03-31 $-99
2022-12-31 $-100
2022-09-30 $-98
2022-06-30 $-98
2022-03-31 $-96
2021-12-31 $-96
2021-09-30 $-93
2021-06-30 $-92
2021-03-31 $-93
2020-12-31 $-93
2020-09-30 $-93
2020-06-30 $-93
2020-03-31 $-97
2019-12-31 $-97
2019-09-30 $-99
2019-06-30 $-100
2019-03-31 $-101
2018-12-31 $-102
2018-09-30 $-102
2018-06-30 $-103
2018-03-31 $-105
2017-12-31 $-106
2017-09-30 $-106
2017-06-30 $-107
2017-03-31 $-107
2016-12-31 $-107
2016-09-30 $-107
2016-06-30 $-109
2016-03-31 $-110
2015-12-31 $-111
2015-09-30 $-113
2015-06-30 $-114
2015-03-31 $-114
2014-12-31 $-112
2014-09-30 $-109
2014-06-30 $-111
2014-03-31 $-111
2013-12-31 $-113
2013-09-30 $-76
2013-06-30 $-76
2013-03-31 $-74
2012-12-31 $-73
2012-09-30 $-73
2012-06-30 $-77
2012-03-31 $-82
2011-12-31 $-77
2011-09-30 $-85
2011-06-30 $-88
2011-03-31 $-41
2010-12-31 $-31
2010-09-30 $-37
2010-06-30 $-38
2010-03-31 $-32
2009-12-31 $-23
2009-09-30 $-23
2009-06-30 $-24
2009-03-31 $-19
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.127B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
West Pharmaceutical Services (WST) United States $22.428B 43.73
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Pro-Dex (PDEX) United States $0.086B 41.13